Haemophilus B and hepatitis B vaccine
Haemophilus B and hepatitis B vaccine is a combination vaccine whose generic name is Haemophilus b conjugate and hepatitis B recombinant vaccine.[1] It protects against the infectious diseases Haemophilus influenzae type B and hepatitis B.
Combination of | |
---|---|
Hib vaccine | Vaccine |
Hepatitis B vaccine | Vaccine |
Clinical data | |
Trade names | Comvax |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Pregnancy category |
|
Routes of administration | Intramuscular injection |
ATC code | |
Identifiers | |
ChemSpider |
|
A branded formulation, Comvax, was marketed in the USA by Merck.[2][3] It was discontinued in 2014.[4]
References
- "Comvax". Drugs.com. Retrieved 15 July 2018.
- "Notice to Readers FDA Approval for Infants of a Haemophilus influenzae Type b Conjugate and Hepatitis B (Recombinant) Combined Vaccine". Morbidity and Mortality Weekly Report. Centers for Disease Control and Prevention. 7 February 1997. pp. 107–109. Retrieved 15 July 2018.
- "Comvax package insert" (PDF). Retrieved 15 July 2018.
- Zarei AE, Almehdar HA, Redwan EM (2016). "Hib Vaccines: Past, Present, and Future Perspectives". Journal of Immunology Research. 2016: 7203587. doi:10.1155/2016/7203587. PMC 4745871. PMID 26904695.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.